original ) (raw )In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder
Dolors BALSA, PhD
British Journal of Pharmacology, 2009
View PDFchevron_right
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
Paul Abrams
British Journal of Pharmacology, 2006
View PDFchevron_right
Muscarinic receptor antagonists for overactive bladder
Paul Abrams
BJU International, 2007
View PDFchevron_right
Antimuscarinics for the treatment of overactive bladder: understanding the role of muscarinic subtype selectivity
K. Glavind
International Urogynecology Journal, 2011
View PDFchevron_right
Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist
Mathai Mammen
European Journal of Pharmacology, 2009
View PDFchevron_right
Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction
Karl-Erik Andersson
British Journal of Clinical Pharmacology, 2011
View PDFchevron_right
M 3 muscarinic receptors mediate contraction of human urinary bladder
Martin Michel
British Journal of Pharmacology, 2002
View PDFchevron_right
Cardiovascular effects of antimuscarinic agents in overactive bladder
Gian Rosa
Expert Opinion on Drug Safety, 2013
View PDFchevron_right
Functional role of M 2 and M 3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo
Douglas Bonhaus
British Journal of Pharmacology, 1997
View PDFchevron_right
Interaction between muscarinic receptor subtype signal transduction pathways mediating bladder contraction
Alan Braverman
American journal of physiology. Regulatory, integrative and comparative physiology, 2002
View PDFchevron_right
AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder
Ashwinkumar Meru
British Journal of Pharmacology, 2010
View PDFchevron_right
Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation
Mathai Mammen
Naunyn-Schmiedeberg's Archives of Pharmacology, 2011
View PDFchevron_right
Muscarinic receptor antagonists for overactive bladder treatment: does one fit all?
Martin Michel
Current Opinion in Urology, 2009
View PDFchevron_right
Effects of NAD-299, a new, highly selective 5-HT 1A receptor antagonist, on bladder function in rats
Karl-Erik Andersson
Naunyn-Schmiedeberg's Archives of Pharmacology, 2002
View PDFchevron_right
Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse
Beate Averbeck
European Journal of Pharmacology, 2002
View PDFchevron_right
Urothelial/Lamina Propria Spontaneous Activity and the Role of M3 Muscarinic Receptors in Mediating Rate Responses to Stretch and Carbachol
R. Chess-Williams
Urology, 2011
View PDFchevron_right
Antimuscarinics for the treatment of overactive bladder: A review of central nervous system effects
Mathai Mammen
Current Urology Reports, 2007
View PDFchevron_right
In vitro functional interactions of acetylcholine esterase inhibitors and muscarinic receptor antagonists in the urinary bladder of the rat
Gunnar Tobin
Clinical and Experimental Pharmacology and Physiology, 2014
View PDFchevron_right
Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors?
Martin Michel
Naunyn-Schmiedeberg's Archives of Pharmacology, 2003
View PDFchevron_right
Exogenous activation of muscarinic receptors decreases subsequent non-muscarinic bladder contractions in vivo in the female rat
Karl Thor
Life sciences, 2013
View PDFchevron_right
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists - a matter of metabolites?
Martin Michel
Naunyn-Schmiedeberg's Archives of Pharmacology, 2006
View PDFchevron_right
Muscarinic receptor subtypes in porcine detrusor: comparison with humans and regulation by bladder augmentation
Martin Michel
Urological Research, 1998
View PDFchevron_right
The M2 Muscarinic Receptor Mediates Contraction through Indirect Mechanisms in Mouse Urinary Bladder
Frederick Ehlert
Journal of Pharmacology and Experimental Therapeutics, 2004
View PDFchevron_right
Selective Alkylation of Rat Urinary Bladder Muscarinic Receptors with 4-DAMP Mustard Reveals a Contractile Function for the M 2 Muscarinic Receptor
Michael Ruggieri
Journal of Receptors and Signal Transduction, 1999
View PDFchevron_right
Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
Kyu-Sung Lee
International Neurourology Journal, 2022
View PDFchevron_right
M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. II. Denervated Rat Bladder
Michael Ruggieri
Journal of Pharmacology and Experimental Therapeutics, 2005
View PDFchevron_right
Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences
Emilio Sacco
International Urogynecology Journal, 2008
View PDFchevron_right
On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder
Gunnar Tobin
European Journal of Pharmacology, 2001
View PDFchevron_right
Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome
Martin Michel
Naunyn-Schmiedeberg's Archives of Pharmacology, 2012
View PDFchevron_right
The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity
Cees Korstanje
European Journal of Pharmacology, 2013
View PDFchevron_right